Newbie Remogliflozin Gives Competition A Run For Their Money

 
• By Anju Ghangurde

Remogliflozin prescriptions gallop in India and Glenmark expects the ‘affordable’ therapy to take share from other SGLT2 inhibitors.

Runners
Competition Heats Up In Indian SGLT2 market • Source: Shutterstock

More from Business

More from Scrip